- 8 things you need to know about the BA.3.2 ‘Cicada’ variant of COVID-19
- Zimbabwean Company Launches Drone Technology to Deliver Medicines and Blood Products
- Two LGBTIQ-Linked Zim NGOs Rejected Under New PVO Decisions
- Egyptian Cardiothoracic Surgeons Lead Zimbabwe’s Third Paediatric Heart Surgery Mission
- Burundi mystery outbreak remains unsolved after More Than 200 pathogen tests
Zimbabwean Company Launches Drone Technology to Deliver Medicines and Blood Products
Michael Gwarisa Drone Solutions, a local logistics company, has introduced drone technology to deliver medicines, blood and blood products, among other essential health commodities, across Zimbabwe. The move is set to address gaps in the healthcare supply chain while tackling persistent challenges such as poor road networks and transport-related delays. It is also expected to
Read More
Two LGBTIQ-Linked Zim NGOs Rejected Under New PVO Decisions
Michael Gwarisa Recent Private Voluntary Organisation (PVO) Board decisions show that most organisations seeking registration under Zimbabwe’s updated regulatory framework have been approved, while a small number have been rejected or deferred for further consideration. Among the organisations affected are two groups linked to sexual and reproductive health and LGBTIQ-related programming: the Sexual Rights Centre,
Read More
Burundi mystery outbreak remains unsolved after More Than 200 pathogen tests
Michael Gwarisa Health authorities are still searching for answers after a cluster of deaths and illnesses in Burundi that has so far defied diagnosis, despite extensive laboratory testing that has ruled out major viral haemorrhagic fevers such as Ebola and Marburg. According to health officials involved in the investigation, hundreds of potential pathogens, including both
Read More
PEPFAR, Global Fund Expand Lenacapavir Access to Reach 3 Million in HIV Prevention Push
Michael Gwarisa Global efforts to scale up access to a groundbreaking HIV prevention injection have received a major boost after PEPFAR and The Global Fund announced additional investment in Gilead Sciences’ long-acting drug, lenacapavir, with the aim of expanding protection to millions at risk. The new commitment will support access for up to an additional
Read More
Low Viral Load Doesn’t Mean Zero Risk: What New Uganda Study Means for U=U
Michael Gwarisa For years, the global HIV response has rallied around a simple but powerful message: Undetectable equals Untransmittable, widely known as U=U. Backed by strong scientific evidence, the concept has transformed both HIV prevention and the lives of people living with the virus. But new findings from the Rakai HIV Cohort Study in Uganda
Read More
Manchester Institute of Biotechnology Develops Cheaper, Sustainable Method to Produce HIV Drug Lenacapavir
Michael Gwarisa Amid growing global pressure to make Lenacapavir more affordable, researchers at the Manchester Institute of Biotechnology have developed a new method that could significantly reduce the cost and improve the sustainability of manufacturing the long-acting HIV prevention drug. Supported by funding from the Gates Foundation, the scientists applied engineering biology, a rapidly advancing
Read More
Zimbabwe Recalls Batch of Azithromycin Over Quality Concerns
Michael Gwarisa The Medicines Control Authority of Zimbabwe (MCAZ) has issued a Class II recall of a specific batch of Azithromycin 500mg USP tablets after a quality defect was detected, raising concerns over the drug’s effectiveness in treating bacterial infections. The affected product, Batch Number 24050191, was manufactured by Indoco Remedies Limited of India. According
Read More
“Gore Mwana” Practice Raises Risk Of Birth Complications, Experts Warn
Michael Gwarisa Zimbabwe’s leading family planning expert and trainer with the Zimbabwe National Family Planning Council (ZNFPC), Thandekile Munemo, has cautioned women against closely spaced pregnancies, warning that insufficient recovery time between births can pose serious health risks for both mothers and children. The concept of “gore mwana mwawa”, a Shona phrase loosely translated as
Read More
Mystery Haemorrhagic Illness Kills Five in Burundi
Michael Gwarisa The World Health Organization (WHO) is supporting Burundi’s efforts to determine the cause of an illness that has led to five deaths and infected 35 people in Mpanda district, north of the East African country. While preliminary assumptions linked the ailment to Ebola or Marburg virus diseases, Rift Valley fever, yellow fever and
Read More
EU Pledges US$750 Million to Fight HIV, TB and Malaria, Boosts AMR Response
Michael Gwarisa Amid declining donor support for health programmes in Africa and globally, the European Union has committed US$750 million (€700 million) to the Global Fund’s 8th replenishment to strengthen the fight against HIV, tuberculosis and malaria. The announcement was made by Jozef Síkela, Commissioner for International Partnerships, at the One Health Summit in Lyon,
Read More